Li-Mou Zheng
Li-Mou Zheng publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Cancer Research and Treatments and Cancer Genomics and Diagnostics.
- World rank
- #1,815,772 of 7,710,434 ranked researchers
- Rank in United States
- #557,487 of 1,627,098
- Works
- 33
- Citations
- 1.6k
- Citations per work
- 48.5
What does Li-Mou Zheng research?
Li-Mou Zheng's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1235.8%
- Medicine1235.8%
- Everything else1030.6%
- Life Sciences721.0%
- Physical Sciences412.6%
- Chemistry26.3%
- Engineering26.3%
- 1Pulmonary and Respiratory Medicine22% of their works
- 2Oncology14% of their works
- 3Cancer Research10% of their works
- 4Biotechnology10% of their works
- 5Biomedical Engineering6% of their works
- 6Organic Chemistry6% of their works
Research topics
Which keywords describe Li-Mou Zheng's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Immunotherapy, ALK Inhibitors, EGFR Mutations, Tumor Targeting, Chemotherapy and Arginine Deprivation.
- Campylobacter
- Photothermal Therapy
- Lung Cancer
- Genomic Profiles
- CT Screening
- Cancer Genomics
- Arginine Deprivation
- Tumor Targeting
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Immunotherapy
- EGFR Mutations
- Chemotherapy
- Bacterial Therapy
- Mutational Signatures
- Cetuximab
- KRAS Mutations
- Nanoparticles
- Small-Cell Lung Cancer
- Salmonella
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Targeted Therapy263 topics
- Clinical Trials182 topics
- Immunotherapy183 topics
- ALK Inhibitors141 topic
- EGFR Mutations141 topic
- Tumor Targeting142 topics
- Chemotherapy123 topics
- Arginine Deprivation101 topic
- Bacterial Therapy101 topic
- Cancer Genomics81 topic
- Mutational Signatures81 topic
- CT Screening41 topic
- Cetuximab41 topic
- Genomic Profiles41 topic
- KRAS Mutations41 topic
- Lung Cancer41 topic
- Nanoparticles41 topic
- Photothermal Therapy41 topic
- Small-Cell Lung Cancer41 topic
- Campylobacter31 topic
- Salmonella31 topic
Where does Li-Mou Zheng work?
Li-Mou Zheng's main affiliation in the publication record is Vion Pharmaceuticals (United States), United States.
How many publications and citations does Li-Mou Zheng have?
OpenAlex counts 33 works and 1,600 citations for Li-Mou Zheng, an h-index of 15, ranking #1,815,772 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Li-Mou Zheng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.